In Section A, contributors will receive diverse doses and schedules of oral ABBV-744 pill to determine Harmless dosing regimen. Added members will probably be enrolled for the discovered monotherapy dosign program. In Segment B, participants will obtain oral ruxolitinib and ABBV-744 are going to be offered as "incorporate-on" therapy. In https://abbv-744-combination-ther45790.yomoblog.com/38352755/what-does-new-advancements-in-brd4-inhibition-therapy-abbv-744-mean